Kidney Transplant Rejection Biomarker Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market Insights

Kidney Transplant Rejection Biomarker Market

Key Insight

Transplant centers represent 44.0% of end user demand, acute rejection detection accounts for 34.0% of application sales and next-generation sequencing (NGS) holds 33.2% within the technology segment in 2026. The kidney transplant rejection biomarker market was valued at USD 1,224.4 million in 2025 and is forecast to post an 11.3% CAGR between 2026 and 2036.

July 23, 2026

Anurag Sharma

250 Pages

Cite this Report

Kidney Transplant Rejection Biomarker Market

https://www.futuremarketinsights.com/reports/kidney-transplant-rejection-biomarker-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Competitive Analysis

Key Players

CareDx
Natera
Verici Dx
Insight Molecular Diagnostics
Eurofins Scientific SE
Thermo Fisher Scientific
Bio-Rad Laboratories

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Kidney Transplant Rejection Biomarker Market

Key Players

Similar Industry Reports